Publications by authors named "Nga V Hawk"

Cholangiocarcinoma is an aggressive type of liver cancer with few effective treatment options. Therefore, there is great need to better understand the biology of this malignancy to further development of novel treatment options. Cancer stem cells (CSCs) are thought to the underlying reason for cancer initiation, metastasis, and relapse.

View Article and Find Full Text PDF

GATA2 is a transcription factor critical for hematopoiesis. Germline mutations in GATA binding protein 2 (GATA2) led to haploinsufficiency, severe cytopenias of multiple cell lineages, susceptibility to infections and strong propensity to develop myelodysplastic syndrome, and acute myeloid leukemia. Mechanisms of progressive cytopenias remain unclear.

View Article and Find Full Text PDF
Article Synopsis
  • T cell senescence and exhaustion limit the effectiveness of cancer immunotherapy.
  • The study demonstrates that miR-155 boosts CD8 T cell function against tumors by preventing senescence and exhaustion through the suppression of certain differentiation drivers.
  • It highlights a key mechanism involving miR-155, Phf19, and the Polycomb repressor complex 2 (PRC2) that together help maintain CD8 T cell activity and differentiation, suggesting potential for enhancing cancer treatments through epigenetic strategies.
View Article and Find Full Text PDF

Naïve and memory T cells co-exist in the peripheral T cell pool, but the cellular mechanisms that maintain the balance and homeostasis of these two populations remain mostly unclear. To address this question, here, we assessed homeostatic proliferation and repopulation kinetics of adoptively transferred naïve and memory T cells in lymphopenic host mice. We identified distinct kinetics of proliferation and tissue-distribution between naïve and memory donor T cells, which resulted in the occupancy of the peripheral T cell pool by mostly naïve-origin T cells in short term (<1 week), but, in a dramatic reversal, by mostly memory-origin T cells in long term (>4 weeks).

View Article and Find Full Text PDF

Stem cells are maintained by transcriptional programs that promote self-renewal and repress differentiation. Here, we found that the transcription factor c-Myb was essential for generating and maintaining stem cells in the CD8 T cell memory compartment. Following viral infection, CD8 T cells lacking Myb underwent terminal differentiation and generated fewer stem cell-like central memory cells than did Myb-sufficient T cells.

View Article and Find Full Text PDF

Cancer stem-like cells are hypothesized to be the major tumor-initiating cell population of human cutaneous squamous cell carcinoma (cSCC), but the landscape of molecular alterations underpinning their signaling and cellular phenotypes as drug targets remains undefined. In this study, we developed an experimental pipeline to isolate a highly enriched CD133CD31CD45CD61CD24 (CD133) cell population from primary cSCC specimens by flow cytometry. The CD133 cells show enhanced stem-like phenotypes, which were verified by spheroid and colony formation and tumor generation Gene expression profiling of CD133 cells was compared and validated, and differentially expressed gene signatures and top pathways were identified.

View Article and Find Full Text PDF

IL-7 is essential for T-cell survival but its availability is limited in vivo. Consequently, all peripheral T cells, including recent thymic emigrants (RTEs) are constantly competing for IL-7 to survive. RTEs are required to replenish TCR diversity and rejuvenate the peripheral T-cell pool.

View Article and Find Full Text PDF

Lymphodepleting regimens are used before adoptive immunotherapy to augment the antitumor efficacy of transferred T cells by removing endogenous homeostatic "cytokine sinks." These conditioning modalities, however, are often associated with severe toxicities. We found that microRNA-155 (miR-155) enabled tumor-specific CD8(+) T cells to mediate profound antitumor responses in lymphoreplete hosts that were not potentiated by immune-ablation.

View Article and Find Full Text PDF
Article Synopsis
  • Smoothened antagonists are drugs that target the genetic causes of basal cell carcinoma (BCC), the most common cancer, inhibiting its growth but not curing it.
  • Researchers found that a small subpopulation of BCC cells (CD200(+) CD45(-)) is crucial for tumor growth, as it can recreate BCC tumors in lab tests, while other cells cannot.
  • The study suggests using anti-CD200 therapy, either alone or alongside Smoothened antagonists, as a new treatment option for patients with inoperable BCC.
View Article and Find Full Text PDF